Schedule 13G/A filed Oct 5. Who filed, the stake, and how it changed.

A nanoscale machine made from DNA moves under external control and prints by selectively modifying pixels on a canvas.

Prepared for Bottlenecks 2021 in Denver CO, reposted here. Summary Nanoscale science and technology broadly has made considerable progress on areas ranging from mRNA vaccine delivery that are impac…

Real-time meetings by Google. Using your browser, share your video, desktop, and presentations with teammates and customers.

Real-time meetings by Google. Using your browser, share your video, desktop, and presentations with teammates and customers.

Real-time meetings by Google. Using your browser, share your video, desktop, and presentations with teammates and customers.

SRI-filtered stock screening report for August 11, 2026. Daily signals with technical analysis and sentiment.

View SEC insider trading activity with readable Form 4 transaction details, buy and sell activity, filing context, and source document access.

View SEC insider trading activity with readable Form 4 transaction details, buy and sell activity, filing context, and source document access.

Click to view the official SEC document.

Click to view the official SEC document.

Click to view the official SEC document.

Real-time meetings by Google. Using your browser, share your video, desktop, and presentations with teammates and customers.

Innovex International (NYSE: INVX) announced an underwritten public offering of 5,000,000 shares of its common stock to be sold by certain affiliates of Amberjack Capital Partners as selling stockholders. Innovex will not issue any new shares in this Offering and will not receive any proceeds.The Offering’s completion is subject to market and other conditions. Barclays will act as sole underwriter and may sell shares on the NYSE, over-the-counter, or through negotiated transactions at prevailing or negotiated prices. The Offering will be made solely via a prospectus supplement and base prospectus under an effective Form S-3 shelf registration filed with the SEC.

Innovex (NYSE: INVX) reported second quarter 2026 revenue of $244.9 million, up 2% sequentially and 9% year-over-year, with net income of $25.0 million (10% margin) and Adjusted EBITDA of $48.0 million (20% margin). Net cash from operating activities was $37.0 million and Free Cash Flow was $30.4 million. The company ended the quarter with $222.1 million of cash and cash equivalents and no bank debt, and reported income from operations of $100 million and ROCE of 12% for the twelve months ended June 30, 2026.Operationally, Innovex won an additional $20 million subsea tension riser award in Malaysia, completed its first XPak trial with a major independent in Asia, and closed the $95 million cash-and-stock acquisition of TCO on July 1, 2026. For Q3 2026, Innovex guides to revenue of $260–$270 million and Adjusted EBITDA of $51–$57 million, including TCO.

Real-time meetings by Google. Using your browser, share your video, desktop, and presentations with teammates and customers.

Innovex International, Inc. today announced that it will release its second quarter 2026 earnings results on August 3, 2026, after the market closes. Management will host a conference call and webcast to discuss the financial results on August 4, 2026, at 9:00 a.m. Eastern Time/ 8:00 a.m. Central Time. The call will be open to all interested parties and may...

Real-time meetings by Google. Using your browser, share your video, desktop, and presentations with teammates and customers.

Real-time meetings by Google. Using your browser, share your video, desktop, and presentations with teammates and customers.